Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SFA Therapeutics
AddedMar 17, 2024
UpdatedJul 3, 2026
SFA Therapeutics

SFA Therapeutics

Series A

SFA Therapeutics: Developing oral drugs to treat cancer and autoimmune diseases by regulating the immune system.

HQ
Jenkintown, PA, US
Founded
2016
Accelerator
Y Combinator logoY CombinatorS21
Overview
Compare
Fundraising
Employees
Website

SFA Therapeutics was founded with the mission to develop therapeutically-tailored oral drugs that regulate the immune system using bacterial metabolites. The company focuses on treating autoimmune diseases and cancers originating from chronic inflammation. Their innovative approach aims to block the root causes of these conditions with safe, orally administered drugs. SFA Therapeutics targets a significant market, addressing the needs of over 100 million patients suffering from autoimmune diseases.

Notable figures affiliated with SFA Therapeutics include experts in immunology and pharmacology, though specific names are not provided. The company has made significant strides in drug development, particularly in creating treatments for psoriasis, liver cancer, and other chronic inflammatory diseases. Their platform promises faster clinical development and safer treatments due to the use of endogenous biosynthetics. SFA Therapeutics is poised to make a substantial impact on the healthcare industry by offering novel solutions for chronic inflammatory conditions.

SFA Therapeutics - Similar Companies

Forward Therapeutics logo

Forward Therapeutics

forward-tx.com

Lapix Therapeutics logo

Lapix Therapeutics

lapix.com

Rise Therapeutics logo

Rise Therapeutics

Invea Therapeutics logo

Invea Therapeutics

inveatx.com

Faeth Therapeutics logo

Faeth Therapeutics

Saphtx logo

Saphtx

Azora Therapeutics logo

Azora Therapeutics

Promakhos Therapeutics logo

Promakhos Therapeutics

promakhos.com

Thetis Pharmaceuticals logo

Thetis Pharmaceuticals

thetispharma.com

Aristea Therapeutics logo

Aristea Therapeutics

Persephone Biosciences logo

Persephone Biosciences

Seres Therapeutics logo

Seres Therapeutics

Athos Therapeutics logo

Athos Therapeutics

athostx.com

Immvention Therapeutix logo

Immvention Therapeutix

Intact Therapeutics logo

Intact Therapeutics

SFA Therapeutics - Quick Facts

Who are SFA Therapeutics' competitors?

Companies similar to SFA Therapeutics include Forward Therapeutics, Lapix Therapeutics, Rise Therapeutics and Invea Therapeutics.

When was SFA Therapeutics founded?

SFA Therapeutics was founded in 2016.

Where is SFA Therapeutics' headquarters located?

SFA Therapeutics' headquarters is located in Jenkintown, PA, US.

When was SFA Therapeutics' last funding round?

SFA Therapeutics' most recent funding round was for $4.5M (USD) in November 2023.

How much has SFA Therapeutics raised to-date?

As of Nov 9, 2023, SFA Therapeutics has raised a total of $8.7M (USD).

How many employees does SFA Therapeutics have?

SFA Therapeutics has 6 employees as of Feb 4, 2024.

SFA Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oral Drugs
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified